BioCatalystWatch
ABCLWorkspace / ABCL / OverviewCompany library
AbCellera Biologics Inc. logo

AbCellera Biologics Inc.

AbCellera Biologics Inc. (ABCL)

Website

Price
Market cap
Next catalystExpected 2027ABCL635 · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

ABCL635

NK3R

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ABCL635

NK3R

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Other pipelines

ABCL385

ABCL646

Undisclosed ion channel

ABCL992

NK3R

Partner / License out

SARS-CoV-2 spike × Spike RBD

PreINDP1P2P3FilingApproved

SARS-CoV-2 spike × Spike RBD

PreINDP1P2P3FilingApproved

History / paused

OX40L

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ABCL PR & News

ABCL SEC archive